Gastric Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 1909-1914
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1909
Table 1 Primer sequence and size of expected PCR products
PrimerSequenceLengh (bp)
β-actin sense5’-AAGGATTCCTATGTGGGC-3’532
antisense5’-CATCTCTTGCTCGAAGTC-3’
TIMP-1 sense5’-CTGTTGGCTGTGAGGAATGCACAG-3’106
antisense5’-TTCAGAGCCTTGGAGGAGCTGGTC-3’
TIMP-2 sense5’-AGACGTAGTGATCGGGCCA-3’490
antisense5’-GTACCACGCGCAAGAACCT-3’
Table 2 Effect of c9,t11-CLA on invasive ability of SGC-7901 cells
GroupsInvasive cell number (-x±s)Inhibitory frequency (%)
200 μmol/L23.2 ± 2.9a53.7
100 μmol/L29.6 ± 3.3a40.9
50 μmol/L35.4 ± 2.8a29.3
25 μmol/L44.9 ± 3.110.4
Negative control50.1 ± 4.60
Table 3 Effect of c9,t11-CLA on migration ability of SGC-7901 cells
GroupsCell number (-x±s)Inhibitory frequency (%)
200 μmol/L50.8 ± 3.3a16.0
100 μmol/L52.5 ± 3.113.2
50 μmol/L54.4 ± 3.910.1
25 μmol/L55.0 ± 4.410.1
Negative control60.5 ± 4.20